Visa, Mastercard To Report Wednesday

TheStreet.com

NEW YORK (TheStreet) -- In the wake of reporting quarterly results new data received by ValuEngine can result in upgrades or downgrades to the stocks I profiled pre-earnings. A stock can also have a ratings change if the directional volatility outruns its price target to the upside and triggers a downgrade, or falls far enough below its price target to merit an upgrade.

Amazon.com ($254.81 vs. $274.70 Friday) has been upgraded to hold from strong sell following its $19.89 price plunge Friday. The stock is still overvalued by 6.0% and is projected to slide another 4.3%, but since this is within a plus/minus 5.0% projection range the upgrade to hold occurred. My semiannual and annual value levels are $241.23 and $226.80 with a weekly pivot at $258.38 and quarterly risky level at $278.28.

Qualcomm ($61.52) has been upgraded to buy from hold as the stock fell below its 200-day simple moving average at $65.66 last Thursday. The stock is 12.3% undervalued and is projected to gain 6.1% over the next 12 months. With this projection above 5.0% the stock merited the upgrade. My annual value level is $53.29 with a weekly pivot at $63.32 and quarterly and semiannual risky levels at $65.63 and $67.43. Last week's high was a test of the zone of risky levels.

Du Pont ($52.90) has been downgraded to sell from hold after the Dow component outran its valuations and forecast projections. The stock has become 7.2% overvalued and is projected to decline 6.0% over the next 12 months justifying the downgrade. My quarterly value level is $42.11 with a weekly pivot at $52.13 and semiannual risky level at $60.06.


Today I profile seven stocks that report quarterly results with the theme of getting a fresh read on big Pharma, healthcare providers and spending via credit cards.

Reading the Table

OV/UN Valued: Stocks with a red number are undervalued by this percentage. Those with a black number are overvalued by that percentage according to ValuEngine.

VE Rating: A "1-engine" rating is a strong sell, a "2-engine" rating is a sell, a "3-engine" rating is a hold, a "4-engine" rating is a buy and a "5-engine" rating is a strong buy.

Last 12-Month Return (%): Stocks with a red number declined by that percentage over the last 12 months. Stocks with a black number increased by that percentage.

Forecast 1-Year Return: Stocks with a red number are projected to decline by that percentage over the next 12 months. Stocks with a black number in the table are projected to move higher by that percentage over the next 12 months.

Value Level: Price at which to enter a GTC limit order to buy on weakness. The letters mean; W-weekly, M-monthly, Q-quarterly, S-semiannual and A-annual.

Pivot: A level between a value level and risky level that should be a magnet during the time frame noted.

Risky Level: Price at which to enter a GTC limit order to sell on strength.


Reporting pre-market Tuesday, Pfizer ($30.09) set a multi-year high at $31.15 on April 23. The weekly chart profile is positive but overbought with the five-week modified moving average at $29.28. My quarterly value level is $27.07 with a weekly risky level is $31.38.

Reporting pre-market Wednesday:

Humana ($73.49) set a multi-year high at $96.46 on Jan. 17, 2012. The weekly chart profile is positive with the five-week MMA at $73.04 and the 200-week SMA at $63.74. My weekly risky level is $76.54.

MasterCard ($535.33) set a multi-year high at $546.90 on April 1. The weekly chart profile shifts to negative with a weekly close below the five-week MMA at $527.40. My semiannual value level is $509.02 with a weekly risky level is $540.46.

Merck ($47.87) set a multi-year high at $48.79 on April 24. The weekly chart profile is positive with the five-week MMA at $45.56. My semiannual value level is $43.41 with an annual pivot at $46.99 and weekly risky level is $48.62.


Reporting after the close on Wednesday is Visa ($167.23) set a multi-year high at $170.99 on April 1. The weekly chart profile shifts to negative with a weekly close below the five-week MMA at $163.59. My semiannual value level is $148.31 with a weekly pivot at $170.47 and quarterly risky level is $179.42.

Reporting pre-market Thursday, Cardinal Health ($43.98) set a multi-year high at $47.23 on March 12. The weekly chart profile shifts to negative on a close this week below the five-week MMA at $43.64. My semiannual value level is $42.22 with a quarterly pivot at $42.52 and quarterly risky level is $45.23.


Reporting pre-market on Friday, WellCare Health Plans ($30.09) set a multi-year high at $74.41 on April 5, 2012. The weekly chart profile shifts to negative on a close this week below the five-week MMA at $57.72. My semiannual value level is $36.67 with a weekly pivot at $59.70 and quarterly risky level at $66.48.

At the time of publication the author held no positions in any of the stocks mentioned.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

View Comments (0)